Is lithium still the gold standard in the treatment of bipolar disorders?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 253, Issue 3, 2003, Pages 113-114

  Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID; TRANQUILIZER;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; EUROPE; LONG TERM CARE; MAJOR DEPRESSION; MANIA; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; HUMAN; STANDARD;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM;

EID: 18744425802     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-003-0426-5     Document Type: Editorial

References (7)

1. Adli M, Bschor T, Canata B, Döpfmer S, Bauer M (1998) Lithium in der Behandlung der akuten Depression. Fortschr Neurol Psychiatr 66:435-441
2. American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151 (Suppl):1-36
3. Baastrup PC, Schou M (1967) Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16:162-172
4. Baldessarini RJ, Tondo L, Hennen J (2001) Reduced suicide risk during long-term treatment with lithium. Ann NY Acad Sci 932:24-43
5. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, Wittlin B, Powell BJ (1999) Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 60:9-21
6. Goodwin FK, Zis AP (1979) Lithium in the treatment of mania: comparisons with neuroleptics. Arch Gen Psychiatry 36:840-844
7. Schou M (1997) Lithium-Behandlung der manisch-depressiven Krankheit. Thieme, Stuttgart